2018 International Congress

Monday, October 8, 2018

1:15pm-2:45pm

“Frequency of autonomic and cardiovascular abnormalities in Mexican patients with early Parkinson’s disease”

J. Balderas, A. Gonzalez (Mexico City, Mexico)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

A bayesian network approach for prediction of future dementia in Parkinson’s disease

P. Surathi, M. Mirian, K. Sundvick, S. Appel-Cresswell, M. McKeown (Vancouver, BC, Canada)

Parkinson's Disease: Cognition  ·  Hall 3FG

1:15pm-2:45pm

A comprehensive digital biomarker active testing and passive monitoring suite for the remote and frequent assessment of motor symptom progression in Parkinson’s disease

K. Taylor, R. Postuma, F. Boess, F. Lipsmeier, T. Kilchenmann, L. Verselis, J. Soto, M. Koller, C. Gossens, A. Post, J. Sevigny, M. Lindemann (Basel, Switzerland)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG

1:15pm-2:45pm

A cortical neural signature of motor interruption in patients with Parkinson’s disease and freezing of gait

J. Baarbé, M. Brown, U. Saha, K. Lizarraga, A. Weissbach, N. Drummond, C. Rinchon, P. Kapoor, J. Saravanamuttu, R. Chen (Toronto, ON, Canada)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG

1:15pm-2:45pm

A detailed clinical study of pain in 1957 participants with Parkinson’s disease

M. Silverdale, C. Kobylecki, L. Kass-Iliyya, P. Martinez-Martin, D. Grosset, M. Hu, M. Lawton, S. Cotterill, R. Chaudhuri, H. Morris, F. Baig, N. Williams, L. Hubbard (Manchester, United Kingdom)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

A Florbetapir [F18] amyloid PET Imaging study in Parkinson’s disease Dementia (PDD): The influence of amyloid deposition on cognitive status and course of disease progression

G. Palermo, G. Aghakhanyan, L. Tommasini, D. Frosini, D. Volterrani, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG

1:15pm-2:45pm

A founder French-Canadian GBA mutation, p.W378G, as a cause for synucleinopathies and Gaucher disease

Z. Gan-Or, J. Ruskey, S. Zhou, L. Roncière, A. Alam, D. Spiegelman, J. Trempe, R. Postuma, N. Dupre, D. Amato (Montreal, QC, Canada)

Parkinson's Disease: Genetics  ·  Hall 3FG

1:15pm-2:45pm

A longitudinal PET study to assess progression of laterality in Parkinson’s disease

AA. Roussakis, N. Lao-Kaim, A. Martin-Bastida, P. Piccini (London, United Kingdom)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG

1:15pm-2:45pm

A metabolomic signature of treated and drug-naïve patients with Parkinson disease: A pilot study

J. Troisi, A. Landolfi, C. Vitale, K. Longo, A. Cozzolino, M. Squillante, M.C. Savanelli, P. Barone, M. AmbonI (Salerno, Italy)

Parkinson's Disease: Pathophysiology  ·  Hall 3FG

1:15pm-2:45pm

A patient with myotonic dystrophy type 1 and parkinsonism

J. Choi, J. Lee, H. Kim, B. Jeon (Seoul, Republic of Korea)

Parkinson's Disease: Pathophysiology  ·  Hall 3FG